Syd Johnson

11.8k citations

80 papers · 9.3k · 2 hit papers · h-index 47

Impact in

Infectious Diseases top 0.2%
- Viral Infections and Vectors
Radiology, Nuclear Medicine and Imaging top 0.2%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Radiology, Nuclear Medicine and Imaging 29
- Monoclonal and Polyclonal Antibodies Research 29
Immunology 29
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 10

Co-authors: Michael Diamond (25 shared papers)Scott Koenig (28 shared papers)Daved H. Fremont (13 shared papers)Robert E. Bird (5 shared papers)Sergey Gorlatov (17 shared papers)Ezio Bonvini (32 shared papers)Karl D. Hardman (3 shared papers)Bennett Kaufman (1 shared paper)
Journals: Cancer Research (10 papers)PLoS Pathogens (9 papers)Journal of Virology (7 papers)Blood (6 papers)The Journal of Infectious Diseases (4 papers)
Partner nations: United States Japan Czechia

In The Last Decade

Syd Johnson

80 papers receiving 8.8k citations

Syd Johnson's Hit Papers

align trajectories log scale

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus 1997 · 534 citations

Peers

Countries citing papers authored by Syd Johnson

Since Specialization

Citations

This map shows the geographic impact of Syd Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syd Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syd Johnson more than expected).

Fields of papers citing papers by Syd Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Syd Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syd Johnson. The network helps show where Syd Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Syd Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Syd Johnson Line = papers co-authored together Syd Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Single-Chain Antigen-Binding Proteins Science ·Robert E. Bird, Karl D. Hardman, James W. Jacobson, Syd Johnson, Bennett Kaufman, Shwu‐Maan Lee, Timothy Lee, Sharon H. Pope, G S Riordan, Marc Whitlow Hit paper breakdown →	1988	1277
2	Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus The Journal of Infectious Diseases ·Syd Johnson, Cynthia N. Oliver, Gregory A. Prince, Val G. Hemming, David S. Pfarr, Sheau‐Chiann Wang, Melissa Dormitzer, J. E. O'GRADY, Scott Koenig, James Tamura, Robert M. Woods, Geetha P. Bansal, Debra A. Couchenour, Eric Tsao, William C. Hall, James F. Young Hit paper breakdown →	1997	534
3	Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus Nature Medicine ·Theodore Oliphant, Michael J. Engle, Grant E. Nybakken, Chris Doane, Syd Johnson, Ling Huang, Sergey Gorlatov, Erin Mehlhop, Anantha Marri, Kyung Min Chung, Gregory D. Ebel, Laura D. Kramer, Daved H. Fremont, Michael Diamond	2005	439
4	Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae Molecular Microbiology ·Carsten Rosenow, Patricia Ryan, Jeffrey N. Weiser, Syd Johnson, Patricia A. Fontán, Åke Örtqvist, H. Robert Masure	1997	404
5	Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial The Lancet ·Nicole Sherry, William Hagopian, Johnny Ludvigsson, Sunil Kumar, Jack Wahlen, Robert J. Ferry, Bruce W. Bode, Stephen Aronoff, Christopher M. Holland, David A Carlin, Karen L. King, Ronald L. Wilder, Stanley R. Pillemer, Ezio Bonvini, Syd Johnson, Kathryn E. Stein, Scott Koenig, Kevan C. Herold, Anastasia G. Daifotis	2011	384
6	Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification PLoS Pathogens ·Scott Balsitis, Katherine L. Williams, Ruben Lachica, Diana Flores, Jennifer L. Kyle, Erin Mehlhop, Syd Johnson, Michael Diamond, P. Robert Beatty, Eva Harris	2010	354
7	Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract Journal of Molecular Biology ·Herren Wu, David S. Pfarr, Syd Johnson, Yambasu A. Brewah, Robert M. Woods, Nita Patel, Wendy I. White, James F. Young, Peter A. Kiener	2007	307
8	Structural basis of West Nile virus neutralization by a therapeutic antibody Nature ·Grant E. Nybakken, Theodore Oliphant, Syd Johnson, Stephen Burke, Michael Diamond, Daved H. Fremont	2005	298
9	Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection Infection and Immunity ·Theresa M. Wizemann, Jon H. Heinrichs, John E. Adamou, Alice L. Erwin, Charles Kunsch, Gil H. Choi, Steven Barash, C A Rosen, H. Robert Masure, Elaine Tuomanen, Anthony Gayle, Yambasu A. Brewah, William T. Walsh, Philip Barren, Raju Lathigra, Mark S. Hanson, Solomon Langermann, Syd Johnson, Scott Koenig	2001	290
10	In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein JNCI Journal of the National Cancer Institute ·David Colcher, Robert E. Bird, Mario Roselli, Katie Hardman, Syd Johnson, Simon Pope, Steven W. Dodd, Michael W. Pantoliano, Diane E. Milenic, J Schlom	1990	265
11	Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus PLoS Pathogens ·Pankaj Pal, Kimberly A. Dowd, James D. Brien, Melissa A. Edeling, Sergey Gorlatov, Syd Johnson, Iris Lee, Wataru Akahata, Gary J. Nabel, Mareike K. S. Richter, Jolanda M. Smit, Daved H. Fremont, Theodore C. Pierson, Mark T. Heise, Michael Diamond	2013	255
12	Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells In vitro and Controls Tumor Expansion In vivo via Low-Affinity Activating Fcγ Receptors Cancer Research ·Jeffrey B. Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, Christopher T. Rankin, Hua Li, Stephen Burke, Ling Huang, Syd Johnson, Ezio Bonvini, Scott Koenig	2007	221
13	Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma Blood ·Paul A. Moore, Wenjun Zhang, G. Jonah Rainey, Steve Burke, Hua Li, Ling Huang, Sergey Gorlatov, Maria Veri, Sudeepta Aggarwal, Yinhua Yang, Kalpana Shah, Linda X. Jin, Sunan Zhang, Leilei He, Tengfei Zhang, Valentina Ciccarone, Scott Koenig, Ezio Bonvini, Syd Johnson	2011	221
14	Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties Breast Cancer Research ·Jeffrey L. Nordstrom, Sergey Gorlatov, Wenjun Zhang, Yinhua Yang, Ling Huang, Steve Burke, Hua Li, Valentina Ciccarone, Téngfēi Zhāng, Jeffrey B. Stavenhagen, Scott Koenig, Stanford J. Stewart, Paul A. Moore, Syd Johnson, Ezio Bonvini	2011	194
15	Identification and Characterization of a Novel Family of Pneumococcal Proteins That Are Protective against Sepsis Infection and Immunity ·John E. Adamou, Jon H. Heinrichs, Alice L. Erwin, William T. Walsh, Tony Gayle, Melissa Dormitzer, Ron Dagan, Yambasu A. Brewah, Philip Barren, Raju Lathigra, Solomon Langermann, Scott Koenig, Syd Johnson	2001	190
16	Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2 Journal of Virology ·Soila Sukupolvi-Petty, S. Kyle Austin, Michael J. Engle, James D. Brien, Kimberly A. Dowd, Katherine L. Williams, Syd Johnson, Rebeca Rico-Hesse, Eva Harris, Theodore C. Pierson, Daved H. Fremont, Michael Diamond	2010	185
17	The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 PLoS Pathogens ·Bimmi Shrestha, James D. Brien, Soila Sukupolvi-Petty, S. Kyle Austin, Melissa A. Edeling, Taekyung Kim, Katie M. O’Brien, Christopher A. Nelson, Syd Johnson, Daved H. Fremont, Michael Diamond	2010	185
18	Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes Diabetes ·William Hagopian, Robert J. Ferry, Nicole Sherry, David A Carlin, Ezio Bonvini, Syd Johnson, Kathryn E. Stein, Scott Koenig, Anastasia G. Daifotis, Kevan C. Herold, Johnny Ludvigsson, (unknown)	2013	184
19	Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants The Journal of Experimental Medicine ·Whitney E. Purtha, Thomas F. Tedder, Syd Johnson, Deepta Bhattacharya, Michael Diamond	2011	175
20	Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion Journal of Molecular Biology ·Syd Johnson, Stephen Burke, Ling Huang, Sergey Gorlatov, Hua Li, Weili Wang, Wenjun Zhang, Nadine Tuaillon, Jonah Rainey, Bhaswati Barat, Yinhua Yang, Linda X. Jin, Valentina Ciccarone, Paul A. Moore, Scott Koenig, Ezio Bonvini	2010	164

About Syd Johnson

Syd Johnson is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Public Health, Environmental and Occupational Health, Infectious Diseases and Oncology, having authored 80 papers that have together received 9.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (29 papers), Mosquito-borne diseases and control (24 papers), CAR-T cell therapy research (18 papers), Viral Infections and Vectors (17 papers), Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Infectious Diseases (2.7k citations), Radiology, Nuclear Medicine and Imaging (2.9k citations), Public Health, Environmental and Occupational Health (2.8k citations), Immunology (2.0k citations) and Virology (358 citations). Syd Johnson has collaborated with scholars based in United States, Japan and Czechia. Frequent co-authors include Michael Diamond, Scott Koenig, Daved H. Fremont, Robert E. Bird, Sergey Gorlatov, Ezio Bonvini, Karl D. Hardman, Bennett Kaufman, Marc Whitlow and James W. Jacobson. Their work appears in journals such as Cancer Research, PLoS Pathogens, Journal of Virology, Blood and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Syd Johnson

Impact in

Papers in i

In The Last Decade

Syd Johnson

Syd Johnson's Hit Papers

Peers

Countries citing papers authored by Syd Johnson

Fields of papers citing papers by Syd Johnson

All Works

About Syd Johnson

Explore authors with similar magnitude of impact

Papers in